Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001628280-25-042171
Filing Date
2025-09-19
Accepted
2025-09-19 16:14:41
Documents
20
Period of Report
2025-09-19

Document Format Files

Seq Description Document Type Size
1 DEF 14A lfvn-20250917.htm   iXBRL DEF 14A 967498
6 lfvn-20250917_g1.jpg GRAPHIC 94360
7 lfvn-20250917_g2.jpg GRAPHIC 95965
8 lfvn-20250917_g3.jpg GRAPHIC 819136
9 lfvn-20250917_g4.jpg GRAPHIC 616755
  Complete submission text file 0001628280-25-042171.txt   5274401

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT lfvn-20250917.xsd EX-101.SCH 2407
3 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT lfvn-20250917_def.xml EX-101.DEF 2448
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT lfvn-20250917_lab.xml EX-101.LAB 2877
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT lfvn-20250917_pre.xml EX-101.PRE 1529
22 EXTRACTED XBRL INSTANCE DOCUMENT lfvn-20250917_htm.xml XML 98809
Mailing Address 3300 TRIUMPH BLVD SUITE 700 LEHI UT 84043
Business Address 3300 TRIUMPH BLVD SUITE 700 LEHI UT 84043 801-432-9000
Lifevantage Corp (Filer) CIK: 0000849146 (see all company filings)

EIN.: 900224471 | Fiscal Year End: 0630
Type: DEF 14A | Act: 34 | File No.: 001-35647 | Film No.: 251326992
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)